Liver cirrhosis: Intravoxel incoherent motion MR imaging-pilot study

Radiology

Volumn 249, Issue 3, 2008, Pages 891-899

  Luciani, Alain ^a   Vignaud, Alexandre ^c   Cavet, Madeleine ^b   Van Nhieu, Jeanne Tran ^a,b   Mallat, Ariane ^a,b   Ruel, Lucile ^b   Laurent, Alexis ^b   Deux, Jean François ^b   Brugieres, Pierre ^b   Rahmouni, Alain ^b  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c France and Siemens Medical Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INTRAVOXEL INCOHERENT MOTION THEORY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; IMAGE QUALITY; LIVER; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PILOT STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHANTOMS, IMAGING; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 58149179092     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2493080080     Document Type: Article

References (36)

1. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007;189:799-806.
2. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007;46: 658-665.
3. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-485.
4. Nasu K, Kuroki Y, Sekiguchi R, Kazama T, Nakajima H. Measurement of the apparent diffusion coefficient in the liver: is it a reliable index for hepatic disease diagnosis? Ra-diat Med 2006;24:438- 444.
5. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fi- brosis. J Magn Reson Imaging 2005;22:80-85.
6. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004;183:677- 680.
7. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226:71-78.
8. Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003;16:132-136.
9. Murtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse- triggered single-shot sequences. Radiology 2002;224:258-264.
10. Moteki T, Horikoshi H, Oya N, Aoki J, Endo K. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images. J Magn Reson Imaging 2002;15:564-572.
11. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210:617- 623.
12. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999;24:456- 461.
13. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
14. Le Bihan D, Turner R, MacFall JR. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989;10:324-337.
15. Hollingsworth KG, Lomas DJ. Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 2006;19:231-235.
16. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234:661-673.
17. Fournier LS, Cuenod CA, de Bazelaire C, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 2004;14:2125-2133.
18. Brugieres P, Thomas P, Maraval A, et al. Water diffusion compartmentation at high b values in ischemic human brain. AJNR Am J Neuroradiol 2004;25:692- 698.
19. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepa-tology 1996;24:289-293.
20. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastogra- phy, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.
21. Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol 2006;18:1321-1325.
22. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
23. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. Cirrhosis: modified caudate-right lobe ratio. Radiology 2002;224:769-774.
24. Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Semin Ultrasound CT MR 2002;23:79-100.
25. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10(S2):S115-S120.
26. Lagarias JC, Reeds JA, Wright MH, Wright PE. Convergence properties of the Nelder- Mead Simplex Method in Low Dimensions. SIAM J Optimization 1998;9:112-147.
27. Tofts PS, Lloyd D, Clark CA, et al. Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Re-son Med 2000;43:368-374.
28. Guan S, Zhou KR, Zhao WD, Peng WJ, Tang F, Mao J. Magnetic resonance diffusion- weighted imaging in the diagnosis of diffuse liver diseases in rats. Chin Med J (Engl) 2005;118:639-644.
29. Moreno AH, Burchell AR, Rousselot LM, Panke WF, Slafsky F, Burke JH. Portal blood flow in cirrhosis of the liver. J Clin Invest 1967;46:436-445.
30. Moreno AH, Rousselot LM, Panke WF, Burke ML. The rate of hepatic blood flow in normal subjects and in patients with portal hypertension. Surg Gynecol Obstet 1960;111:443-450.
31. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001; 176:667-673.
32. Hashimoto K, Murakami T, Dono K, et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep 2006;16:677-683.
33. Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992;27:171- 178.
34. Van Beers BE, Grandin C, Pauwels S, et al. Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake. J Magn Reson Imaging 1994;4:351-354.
35. Zipprich A, Steudel N, Behrmann C, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepa-tology 2003;37:385-392.
36. Yagyu Y, Awai K, Inoue M, et al. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. AJR Am J Roentgenol 2005;184:1535-1540.